The global CAR T-Cell-Based Drug market was valued at 4720 million in 2024 and is projected to reach US$ 31340 million by 2031, at a CAGR of 31.8% during the forecast period.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient\"s T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR T-Cell-Based Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell-Based Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell-Based Drug. This report contains market size and forecasts of CAR T-Cell-Based Drug in global, including the following market information:
Global CAR T-Cell-Based Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five CAR T-Cell-Based Drug companies in 2024 (%)
Total Market by Segment:
Global CAR T-Cell-Based Drug market, by Type, 2020-2025, 2026-2031 ($ millions)
Global CAR T-Cell-Based Drug market segment percentages, by Type, 2024 (%)
CD19-targeted
BCMA-targeted
Global CAR T-Cell-Based Drug market, by Application, 2020-2025, 2026-2031 ($ millions)
Global CAR T-Cell-Based Drug market segment percentages, by Application, 2024 (%)
Lymphoma
Multiple Myeloma
Global CAR T-Cell-Based Drug market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global CAR T-Cell-Based Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell-Based Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies CAR T-Cell-Based Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-Cell-Based Drug, market overview.
Chapter 2: Global CAR T-Cell-Based Drug market size in revenue.
Chapter 3: Detailed analysis of CAR T-Cell-Based Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-Cell-Based Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell-Based Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global CAR T-Cell-Based Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell-Based Drug Overall Market Size
2.1 Global CAR T-Cell-Based Drug Market Size: 2024 VS 2031
2.2 Global CAR T-Cell-Based Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell-Based Drug Players in Global Market
3.2 Top Global CAR T-Cell-Based Drug Companies Ranked by Revenue
3.3 Global CAR T-Cell-Based Drug Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell-Based Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies CAR T-Cell-Based Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 CAR T-Cell-Based Drug Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell-Based Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell-Based Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global CAR T-Cell-Based Drug Market Size Markets, 2024 & 2031
4.1.2 CD19-targeted
4.1.3 BCMA-targeted
4.2 Segmentation by Type - Global CAR T-Cell-Based Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global CAR T-Cell-Based Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global CAR T-Cell-Based Drug Revenue, 2026-2031
4.2.3 Segmentation by Type - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global CAR T-Cell-Based Drug Market Size, 2024 & 2031
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 Segmentation by Application - Global CAR T-Cell-Based Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global CAR T-Cell-Based Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global CAR T-Cell-Based Drug Revenue, 2026-2031
5.2.3 Segmentation by Application - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global CAR T-Cell-Based Drug Market Size, 2024 & 2031
6.2 By Region - Global CAR T-Cell-Based Drug Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell-Based Drug Revenue, 2020-2025
6.2.2 By Region - Global CAR T-Cell-Based Drug Revenue, 2026-2031
6.2.3 By Region - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America CAR T-Cell-Based Drug Revenue, 2020-2031
6.3.2 United States CAR T-Cell-Based Drug Market Size, 2020-2031
6.3.3 Canada CAR T-Cell-Based Drug Market Size, 2020-2031
6.3.4 Mexico CAR T-Cell-Based Drug Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell-Based Drug Revenue, 2020-2031
6.4.2 Germany CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.3 France CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.4 U.K. CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.5 Italy CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.6 Russia CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.7 Nordic Countries CAR T-Cell-Based Drug Market Size, 2020-2031
6.4.8 Benelux CAR T-Cell-Based Drug Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell-Based Drug Revenue, 2020-2031
6.5.2 China CAR T-Cell-Based Drug Market Size, 2020-2031
6.5.3 Japan CAR T-Cell-Based Drug Market Size, 2020-2031
6.5.4 South Korea CAR T-Cell-Based Drug Market Size, 2020-2031
6.5.5 Southeast Asia CAR T-Cell-Based Drug Market Size, 2020-2031
6.5.6 India CAR T-Cell-Based Drug Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America CAR T-Cell-Based Drug Revenue, 2020-2031
6.6.2 Brazil CAR T-Cell-Based Drug Market Size, 2020-2031
6.6.3 Argentina CAR T-Cell-Based Drug Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, 2020-2031
6.7.2 Turkey CAR T-Cell-Based Drug Market Size, 2020-2031
6.7.3 Israel CAR T-Cell-Based Drug Market Size, 2020-2031
6.7.4 Saudi Arabia CAR T-Cell-Based Drug Market Size, 2020-2031
6.7.5 UAE CAR T-Cell-Based Drug Market Size, 2020-2031
7 Companies Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell-Based Drug Major Product Offerings
7.1.4 Novartis CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell-Based Drug Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Corporate Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell-Based Drug Major Product Offerings
7.4.4 J & J CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell-Based Drug Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics
7.7.1 CARsgen Therapeutics Corporate Summary
7.7.2 CARsgen Therapeutics Business Overview
7.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.7.5 CARsgen Therapeutics Key News & Latest Developments
7.8 Autolus Therapeutics
7.8.1 Autolus Therapeutics Corporate Summary
7.8.2 Autolus Therapeutics Business Overview
7.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.8.5 Autolus Therapeutics Key News & Latest Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Corporate Summary
7.9.2 Sorrento Therapeutics Business Overview
7.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.9.5 Sorrento Therapeutics Key News & Latest Developments
7.10 Mustang Bio
7.10.1 Mustang Bio Corporate Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio CAR T-Cell-Based Drug Major Product Offerings
7.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.10.5 Mustang Bio Key News & Latest Developments
7.11 Bluebird Bio
7.11.1 Bluebird Bio Corporate Summary
7.11.2 Bluebird Bio Business Overview
7.11.3 Bluebird Bio CAR T-Cell-Based Drug Major Product Offerings
7.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.11.5 Bluebird Bio Key News & Latest Developments
7.12 Cellectis
7.12.1 Cellectis Corporate Summary
7.12.2 Cellectis Business Overview
7.12.3 Cellectis CAR T-Cell-Based Drug Major Product Offerings
7.12.4 Cellectis CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.12.5 Cellectis Key News & Latest Developments
7.13 Allogene Therapeutics
7.13.1 Allogene Therapeutics Corporate Summary
7.13.2 Allogene Therapeutics Business Overview
7.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Major Product Offerings
7.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.13.5 Allogene Therapeutics Key News & Latest Developments
7.14 Celyad
7.14.1 Celyad Corporate Summary
7.14.2 Celyad Business Overview
7.14.3 Celyad CAR T-Cell-Based Drug Major Product Offerings
7.14.4 Celyad CAR T-Cell-Based Drug Revenue in Global Market (2020-2025)
7.14.5 Celyad Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. CAR T-Cell-Based Drug Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell-Based Drug Market Drivers in Global Market
Table 3. CAR T-Cell-Based Drug Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell-Based Drug in Global Market
Table 5. Top CAR T-Cell-Based Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global CAR T-Cell-Based Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global CAR T-Cell-Based Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies CAR T-Cell-Based Drug Product Type
Table 9. List of Global Tier 1 CAR T-Cell-Based Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell-Based Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global CAR T-Cell-Based Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global CAR T-Cell-Based Drug Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue, (US$, Mn), 2026-2031
Table 30. Novartis Corporate Summary
Table 31. Novartis CAR T-Cell-Based Drug Product Offerings
Table 32. Novartis CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Corporate Summary
Table 35. Gilead Sciences CAR T-Cell-Based Drug Product Offerings
Table 36. Gilead Sciences CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Corporate Summary
Table 39. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offerings
Table 40. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Corporate Summary
Table 43. J & J CAR T-Cell-Based Drug Product Offerings
Table 44. J & J CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Corporate Summary
Table 47. JW Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 48. JW Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Corporate Summary
Table 51. FOSUNKite CAR T-Cell-Based Drug Product Offerings
Table 52. FOSUNKite CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics Corporate Summary
Table 55. CARsgen Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 56. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 57. CARsgen Therapeutics Key News & Latest Developments
Table 58. Autolus Therapeutics Corporate Summary
Table 59. Autolus Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 60. Autolus Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Autolus Therapeutics Key News & Latest Developments
Table 62. Sorrento Therapeutics Corporate Summary
Table 63. Sorrento Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 64. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Sorrento Therapeutics Key News & Latest Developments
Table 66. Mustang Bio Corporate Summary
Table 67. Mustang Bio CAR T-Cell-Based Drug Product Offerings
Table 68. Mustang Bio CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Mustang Bio Key News & Latest Developments
Table 70. Bluebird Bio Corporate Summary
Table 71. Bluebird Bio CAR T-Cell-Based Drug Product Offerings
Table 72. Bluebird Bio CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 73. Bluebird Bio Key News & Latest Developments
Table 74. Cellectis Corporate Summary
Table 75. Cellectis CAR T-Cell-Based Drug Product Offerings
Table 76. Cellectis CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Cellectis Key News & Latest Developments
Table 78. Allogene Therapeutics Corporate Summary
Table 79. Allogene Therapeutics CAR T-Cell-Based Drug Product Offerings
Table 80. Allogene Therapeutics CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 81. Allogene Therapeutics Key News & Latest Developments
Table 82. Celyad Corporate Summary
Table 83. Celyad CAR T-Cell-Based Drug Product Offerings
Table 84. Celyad CAR T-Cell-Based Drug Revenue (US$, Mn) & (2020-2025)
Table 85. Celyad Key News & Latest Developments
List of Figures
Figure 1. CAR T-Cell-Based Drug Product Picture
Figure 2. CAR T-Cell-Based Drug Segment by Type in 2024
Figure 3. CAR T-Cell-Based Drug Segment by Application in 2024
Figure 4. Global CAR T-Cell-Based Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global CAR T-Cell-Based Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global CAR T-Cell-Based Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by CAR T-Cell-Based Drug Revenue in 2024
Figure 9. Segmentation by Type – Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global CAR T-Cell-Based Drug Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 13. By Region - Global CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 14. By Country - North America CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 15. United States CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 16. Canada CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 19. Germany CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 20. France CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 22. Italy CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 23. Russia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 27. China CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 28. Japan CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 31. India CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 33. Brazil CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa CAR T-Cell-Based Drug Revenue Market Share, 2020-2031
Figure 36. Turkey CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 37. Israel CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 39. UAE CAR T-Cell-Based Drug Revenue, (US$, Mn), 2020-2031
Figure 40. Novartis CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Gilead Sciences CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. J & J CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. JW Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. FOSUNKite CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Autolus Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Mustang Bio CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Bluebird Bio CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Cellectis CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Allogene Therapeutics CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Celyad CAR T-Cell-Based Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
